Tom Cole

3.9k total citations
17 papers, 476 citations indexed

About

Tom Cole is a scholar working on Virology, Epidemiology and Immunology. According to data from OpenAlex, Tom Cole has authored 17 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Virology, 4 papers in Epidemiology and 4 papers in Immunology. Recurrent topics in Tom Cole's work include HIV Research and Treatment (5 papers), Reproductive tract infections research (3 papers) and Immunotherapy and Immune Responses (3 papers). Tom Cole is often cited by papers focused on HIV Research and Treatment (5 papers), Reproductive tract infections research (3 papers) and Immunotherapy and Immune Responses (3 papers). Tom Cole collaborates with scholars based in United Kingdom, United States and Italy. Tom Cole's co-authors include Robin J. Shattock, David Barrett, Mark D. Griffiths, Hannah M. Cheeseman, Leon R. McFarlane, Suzanne Day, Anja Weinreich Olsen, Frank Follmann, David Lewis and Karen Smith Korsholm and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Tom Cole

16 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Cole United Kingdom 10 163 118 102 98 63 17 476
Varun C. Anipindi Canada 10 232 1.4× 112 0.9× 58 0.6× 93 0.9× 22 0.3× 13 460
Elisa Saba Italy 8 179 1.1× 112 0.9× 73 0.7× 91 0.9× 52 0.8× 14 433
Marzia Rossi Italy 11 182 1.1× 402 3.4× 80 0.8× 99 1.0× 58 0.9× 23 653
F. Bouscarat France 14 193 1.2× 339 2.9× 72 0.7× 39 0.4× 79 1.3× 65 836
Jacob Schiff Canada 10 219 1.3× 72 0.6× 165 1.6× 31 0.3× 80 1.3× 16 584
Rodolfo D. Vicetti Miguel United States 15 333 2.0× 153 1.3× 71 0.7× 278 2.8× 35 0.6× 32 611
Anna Gibbs Sweden 10 825 5.1× 162 1.4× 68 0.7× 28 0.3× 106 1.7× 13 1.0k
Christine Mant United Kingdom 15 119 0.7× 345 2.9× 90 0.9× 30 0.3× 86 1.4× 27 578
Chunhui Wang China 14 182 1.1× 374 3.2× 179 1.8× 86 0.9× 113 1.8× 33 808
Jacqueline A. Wright United States 14 574 3.5× 131 1.1× 86 0.8× 163 1.7× 44 0.7× 15 734

Countries citing papers authored by Tom Cole

Since Specialization
Citations

This map shows the geographic impact of Tom Cole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Cole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Cole more than expected).

Fields of papers citing papers by Tom Cole

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Cole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Cole. The network helps show where Tom Cole may publish in the future.

Co-authorship network of co-authors of Tom Cole

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Cole. A scholar is included among the top collaborators of Tom Cole based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Cole. Tom Cole is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Day, Suzanne, Charandeep Kaur, Hannah M. Cheeseman, et al.. (2022). Comparison of blood and lymph node cells after intramuscular injection with HIV envelope immunogens. Frontiers in Immunology. 13. 991509–991509. 7 indexed citations
2.
Elliott, Tamara, Hannah M. Cheeseman, Abbey Evans, et al.. (2022). Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines. PLoS Pathogens. 18(10). e1010885–e1010885. 15 indexed citations
3.
Pinato, David J., Alessio Cortellini, Tom Cole, et al.. (2021). PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma. BMC Cancer. 21(1). 301–301. 58 indexed citations
4.
Pinato, David J., Alessio Cortellini, Madhava Pai, et al.. (2021). PRIME-HCC: Phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma.. Journal of Clinical Oncology. 39(15_suppl). e16131–e16131. 3 indexed citations
5.
Yao, Zhangting, Bhavna Murali, Qihao Ren, et al.. (2020). Therapy-Induced Senescence Drives Bone Loss. Cancer Research. 80(5). 1171–1182. 84 indexed citations
6.
Sharma, Rohini, Marianna Inglese, Suraiya Dubash, et al.. (2019). [18F]Fluciclatide PET as a biomarker of response to combination therapy of pazopanib and paclitaxel in platinum-resistant/refractory ovarian cancer. European Journal of Nuclear Medicine and Molecular Imaging. 47(5). 1239–1251. 14 indexed citations
7.
Abraham, Sonya, Helene Bæk Juel, Peter Fibiger Bang, et al.. (2019). Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial. The Lancet Infectious Diseases. 19(10). 1091–1100. 135 indexed citations
8.
9.
Sinclair, Jonathan, Tom Cole, & Jim Richards. (2016). The influence of barefoot and shod running on Triceps-surae muscle strain characteristics. CLOK (University of Central Lancashire). 1 indexed citations
10.
Lewis, D. J., Carol Fraser, Rebecca Wiggins, et al.. (2011). Phase I Randomised Clinical Trial of an HIV-1CN54, Clade C, Trimeric Envelope Vaccine Candidate Delivered Vaginally. PLoS ONE. 6(9). e25165–e25165. 40 indexed citations
11.
Donnelly, Louise, Rhonda M. Curran, John S. Tregoning, et al.. (2011). Intravaginal immunization using the recombinant HIV-1 clade-C trimeric envelope glycoprotein CN54gp140 formulated within lyophilized solid dosage forms. Vaccine. 29(27). 4512–4520. 21 indexed citations
12.
Arias, Mauricio A., David Fairhurst, Mark Mitchnick, et al.. (2010). Carnauba wax nanoparticles enhance strong systemic and mucosal cellular and humoral immune responses to HIV-gp140 antigen. Vaccine. 29(6). 1258–1269. 25 indexed citations
14.
Cole, Tom, David Barrett, & Mark D. Griffiths. (2010). Social Facilitation in Online and Offline Gambling: A Pilot Study. International Journal of Mental Health and Addiction. 9(3). 240–247. 32 indexed citations
15.
Lovett, Steve & Tom Cole. (2003). An Empirical Study on Job Differentiation and Tenure. The Journal of Applied Management and Entrepreneurship. 8(3). 3. 5 indexed citations
16.
Kennedy, Robert H., et al.. (2002). Reservoir Characterization Based on Design and Operational Considerations. Journal of Freshwater Ecology. 17(3). 369–374. 2 indexed citations
17.
Martin, James L., et al.. (1999). Two-Dimensional Water Quality Modeling Using CE-QUAL-W2 on Selected Reservoirs. SMARTech Repository (Georgia Institute of Technology).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026